Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1976-7-6
|
pubmed:abstractText |
Cephalothin (1 g every 2 h), buffered cephalothin, and diluent alone (5% dextrose in water) were each administered for 4 days intravenously to 12 volunteers in a double-blind crossover study. The incidence of phlebitis with buffered cephalothin was significantly lower than that with unbuffered drug (P < 0.01) and almost identical to the incidence with diluent alone.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/1267438-235342,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1267438-4819440,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1267438-4840431,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1267438-5687385
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0066-4804
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
646-8
|
pubmed:dateRevised |
2010-9-7
|
pubmed:meshHeading | |
pubmed:year |
1976
|
pubmed:articleTitle |
Significant reduction in the incidence of phlebitis with buffered versus unbuffered cephalothin.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|